Perspectives on benefits and risks of creation of an “injection drug use” billing code

By sjmartinez • May 13, 2024

Sundaram G, Sato T, Goodman-Meza D, Haddad M, Thakarar K, Feinberg J, Springer SA, Barton K, Butler N, Eaton EF, Wurcel AG. Perspectives on benefits and risks of creation of an "injection drug use" billing code. J Subst Use Addict Treat. 2024 May 10:209392. doi: 10.1016/j.josat.2024.209392. Epub ahead of print. PMID: 38735482.

Tags: Infectious Diseases, Publications

The Use of Genetics and Immunology in the Diagnosis and Care of Advanced Coccidioidomycosis: Where Are We Going?

Thiagarajan K, Mishra S, Purdie R, Torres B, Johnson RH, Butte MJ. The Use of Genetics and Immunology in the Diagnosis and Care of Advanced[...]

Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2

Grinspoon SK, Zhao S, Martinez E, Fichtenbaum CJ, Chu SM, Diggs MR, Umbleja T, McCallum S, Fitch KV, Triant VA, Currier JS, Aberg JA, Malvestutto[...]

Preferences for HIV prevention conditional cash transfers among Black/African American and Latinx cisgender MSM in Los Angeles

Moucheraud C, Trujillo D, Wagner Z, Garland W, Smith T, Hoffman RM, Landovitz RJ. Preferences for HIV prevention conditional cash transfers among Black/African American and[...]